The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Gastrointestinal stromal tumor associated with neurofibromatosis type I.
Toshirou Nishida
Consultant or Advisory Role - Novartis
Honoraria - Bayer; Novartis; Pfizer
Research Funding - Novartis
Tsuyoshi Takahashi
No relevant relationships to disclose
Mari Kaneda
No relevant relationships to disclose
Maiko Ako
No relevant relationships to disclose
Takeshi Omori
No relevant relationships to disclose
Toru Masuzawa
No relevant relationships to disclose
Satoshi Serada
No relevant relationships to disclose
Tetsuji Naka
No relevant relationships to disclose
Masahiko Tsujimoto
No relevant relationships to disclose
Seiichi Hirota
No relevant relationships to disclose